EFFICACY OF SUBLINGUAL VERSUS ORAL PIROXICAM IN MANAGEMENT OF POST-SURGICAL PAIN, SWELLING AND TRISMUS AFTER LOWER 3RD MOLAR SURGERY- A RANDOMIZED CONTROL CLINICAL TRIAL

Abstract

Background of the study: Third molar surgical removal is a common procedure in oral and maxillofacial surgery, causing moderate to severe pain, swelling, and trismus. Postoperative pain control improves patient recovery and oral function, with commonly used analgesics including Ibuprofen, Aceclofenac, Ketorolac, Tramadol, Paracetamol, Nalbuphine, Nimusulide, and Buprenorphine.

Aim and Objective:  The study compares oral and sub-lingual Piroxicam for managing post-surgical pain after extraction of impacted third molars, focusing on analgesia onset, pain intensity, swelling, and trismus degree.

Materials and method:  A randomized control trial was conducted on 30 patients who underwent surgical removal of mandibular impacted third molars. The patients were divided into two groups: Group I (Study) and Group II (Control). All patients underwent the procedure by a single surgeon. Post-operative medications were prescribed according to the study design, with Piroxicam 20mg administered sub-lingually (Group I) and 20mg orally (Group II). The parameters were assessed and measured for both groups, and the results and statistical analysis were compared.

Result: The results revealed that the inter-group difference for the post-operative symptoms evaluated using a t-test for Equality of means by comparing the pre-op, POD 2, POD 7 values was statistically significant. Mean onset time taken and pain perception by Group I (Sub-lingual) in the first dose was 32.3 minutes and for Group II was 51.21 minutes which was established to be significantly (P<0.05) low for the sub-lingual group by statistical analysis. 

Conclusion: The study found that the sublingual route of administering Piroxicam had a faster onset of action and better analgesia postoperatively compared to the oral route. This is crucial for patients and surgeons to improve compliance and comfort post-operatively after impaction surgery, as potent analgesics are essential for effective pain management.

Keywords:

Piroxicam, Sublingual route, Post Surgical Complications, Analgesics, Pain, 3rd Molar surgery

References

Blondeau F, Daniel NG. Extraction of impacted mandibular third molars: postoperative complications and their risk factors. J Can Dent Assoc. 2007.

LJ Balihallimath, Shruti SP. Sublingual piroxicam for management of postoperative pain, trismus and swelling after extraction of lower third molars: an overview. IOSR Journal of Dental and Medical Sciences. Volume 14, Issue 10 Ver. VIII (Oct. 2015).

Lee Y, Rodiguez C, Dionne RA. The role of cox-2 in acute pain and the use of selective cox-2 inhibiors for acute pain relief. Curr Pharm Des 2005.

R. N. Brogden, R. C. Heel, T. M. Speight, G. S. Avery. Piroxicam A Reappraisal of its Pharmacology and Therapeutic Efficacy. Drugs.October 1984.

P. A. K. Trindade, F. P. M. Giglio et Al . Comparison of oral versus sublingual piroxicam during postoperative pain management after lower third molar extraction. Int. J. Oral Maxillofac. Surg. 2011.

Saha P, Verma SU, Das PS. Sublingual drug delivery: an indication of a potential alternative route. International Journal of Current Pharmaceutical Research. 2017.

Kaur N, Misurya R, Narula R, Kumar M. Comparison of the clinical efficacy of methylprednisolone with ibuprofen and ibuprofen alone on the postoperative sequelae of surgical removal of the impacted third molar. Indian Journal of Pain. 2014.

Schultze-Mosgau S, Schmelzeisen R, Frölich JC, Schmele H. Use of ibuprofen and methylprednisolone for the prevention of pain and swelling after removal of impacted third molars. Journal of oral and maxillofacial surgery.1995.

Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno MR, Harris JD. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews. 2018.

Gintaras Juodzbalys , Povilas Daugela; Mandibular Third Molar Impaction: Review of Literature and a Proposal of a Classification; J Oral Maxillofac Res. 2013.

Singh AK. Complications Associated with Surgical Removal of Mandibular Third Molar: A Prospective Study. J Nep Dental Association. 2019.

Nazar MN, Puthiriraj V. Analgesics following mandibular third molar surgery. Int J Pharm Clin Res. 2014.

Barden J, Edwards JE, McQuay HJ, Moore RA. Pain and analgesic response after third molar extraction and other postsurgical pain. Pain. 2004.

Levrini L, Carraro M, Rizzo S, Salgarello S, Bertelli E, Pelliccioni GA, Garau V, Bandettini M, Caputi S, L철rincz A, Sz청cs A. Prescriptions of NSAIDs to patients undergoing third molar surgery. Clinical drug investigation. 2008.

Lustenberger FD, Grätz KW, Mutzbauer TS. Efficacy of ibuprofen versus lornoxicam after third molar surgery: a randomized, double-blind, crossover pilot study. Oral and maxillofacial surgery. 2011.

Pawar PP, Ghorpade HS, Kokane BA. Sublingual route for systemic drug delivery. Journal of Drug Delivery and Therapeutics. 2018.

Elsey MJ, Rock WP. Influence of orthodontic treatment on the development of third molars. Br J Oral Maxillofac Surg. 2000.

Richman MD, Fox D, Shangraw RF. Preparation and stability of glyceryl trinitrate sublingual tablets prepared by direct compression. J Pharm Sci 1965.

Neha Narang , Jyoti Sharma; Sublingual Mucosa As A Route For Systemic Drug Delivery, Int J Pharm Pharm Sci, Vol 3, Suppl 2, 2011.

Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clinical pharmacokinetics. 2002 Aug;41:661-80.

Agarwal P, Kumar HS, Rai KK. Trismus in oral cancer patients undergoing surgery and radiotherapy. Journal of oral biology and craniofacial research. 2016 Nov 1;6:S9-13.

Alpaslan C, Alpaslan G et Al. Postoperative pain control by single doses of piroxicam administered sublingually and aspirin. J Marmara Univ Dent Fac. 1997.